Molecular Nutrition & Food Research · 2021 · 36 citations · 23 references
Life SciencesImmunologyPharmacologyImmunopathologyInflammationInnate ImmunityGastrointestinal ImmunologyGastrointestinal InflammationGut MicrobiotaMucosal ImmunityMucosal ImmunopathologyMucosal InflammationDrug-induced Mucosal InjuryIntestinal Microbiota EffectsIntestinal Microbiota ModulationPectin Biology
SCOPE: Intestinal mucositis is a common side effect of the chemotherapeutic agent doxorubicin, which is characterized by severe Toll-like receptor (TLR) 2-mediated inflammation. The dietary fiber pectin is shown to prevent this intestinal inflammation through direct inhibition of TLR2 in a microbiota-independent manner. Recent in vitro studies show that inhibition of TLR2 is determined by the number and distribution of methyl-esters of pectins. Therefore, it is hypothesized that the degree of methyl-esterification (DM) and the degree of blockiness (DB) of pectins determine attenuating efficacy on doxorubicin-induced intestinal mucositis. METHODS AND RESULTS: Four structurally different pectins that differed in DM and DB are tested on inhibitory effects on murine TLR2 in vitro, and on doxorubicin-induced intestinal mucositis in mice. These data demonstrate that low DM pectins or intermediate DM pectins with high DB have the strongest inhibitory impact on murine TLR2-1 and the strongest attenuating effect on TLR2-induced apoptosis and peritonitis. Intermediate DM pectin with a low DB is, however, also effective in preventing the induction of doxorubicin-induced intestinal damage. CONCLUSION: These pectin structures with stronger TLR2-inhibiting properties may prevent the development of doxorubicin-induced intestinal damage in patients undergoing chemotherapeutic treatment with doxorubicin.
23
Crystal Structure of the TLR1-TLR2 Heterodimer Induced by Binding of a Tri-Acylated Lipopeptide
Mi Sun Jin, Sung Eun Kim, Jin Young Heo et al. · Cell · 2007 · 1.3K citations · Full text
Linda S. Elting, Catherine D. Cooksley, Mark S. Chambers et al. · Cancer · 2003 · 615 citations · Full text
Medicine, Oncology, Pharmacology +13